Strategic Partners A/S (STRAP.CO)

Full history for every metric is available with a Kvantra account

Stock profile
Strategic Partners A/S logo

Strategic Partners A/S (STRAP.CO)

Country: DenmarkSector: HealthcareIndustry: BiotechnologyExchange: CPH
P/E TTM
N/A
History
P/E NTM
N/A
Market cap
26.46M
Currency DKK
KvantraRankAbout69
IValue58
IIQuality71
IIIMomentum81
Current price
640.00 DKK0.00%
Benchmarks

No price history available.

Key financial summary

Financials in DKK
202020212022202320242025TTM2026E
Total revenueDKK m03600000-
Operating profitDKK m-2-2
Net profitDKK m-633-627-111-26-0-11-
EPS reportedDKK-21.0032.29
Operating cashflow per shareDKK-51.2127.64
Capex per shareDKK0.000.00
FCF per shareDKK-51.2127.64
Free cash flowDKK m-21
Net debtDKK m-16-17
Book value equityDKK m1819
Book value per shareDKK440.9465.2
Number of sharesm0.040.04
DPS (TTM paid)DKK0.000.00

Financial summary

Financials in DKK
202020212022202320242025TTM2026E
Value
P/E TTMx--
P/B LTMx1.581.50
P/S LTMx94.2271.19
P/FCF LTMx-13.6325.25
EV/EBITDA LTMx-11.74-14.92
EV/Sales LTMx92.9575.14
Earnings Yield LTM%-2.95%+4.33%
FCF Yield%-7.34%+3.96%
Quality
ROE%-4.67%+7.13%
ROIC%-13.30%-9.92%
Operating margin%-7.92%-4.71%
Gross margin%+100.00%+75.55%
FCF/Sales%-691.26%+281.91%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%--
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%--
Payout Ratio%0.00%0.00%
FCF/Debtx--
Net Debt/EBITDAx0.160.04
EBIT/Net interestx0.000.00
Net debt/market cap%0.00%0.00%
Net debt/Equityx-0.87-0.85
Gross debt/equityx0.000.00

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

Strategic Partners A/S currently conducts minimal business operations. Its previous activities centered on the field of biotechnology. The firm, originally known as Orphazyme A/S, adopted the new moniker Strategic Partners A/S in October 2024. Established in 2009, the company's base of operations is situated in Herlev, Denmark.

SectorHealthcare
IndustryBiotechnology
CountryDenmark
Trades inDKK

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Strategic Partners A/S (STRAP.CO)

STRAP.CO · CPH · Healthcare
640.00 DKK0.00%
Sign up to track this stock

No price history available.

KvantraRank69
Market cap26.46M
P/E NTMN/A
P/E TTMN/A
KvantraRank?69 / 100
Value
58
Quality
71
Momentum
81
Financialsin DKK
20242025TTM2026E
Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

About

Strategic Partners A/S currently conducts minimal business operations. Its previous activities centered on the field of biotechnology. The firm, originally known as Orphazyme A/S, adopted the new moniker Strategic Partners A/S in October 2024. Established in 2009, the company's base of operations is situated in Herlev, Denmark.

SectorHealthcare
IndustryBiotechnology
CountryDenmark
Trades inDKK

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free